Adage Capital Partners Gp, L.L.C. Arcturus Therapeutics Holdings Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51 Billion
- Q1 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 450,000 shares of ARCT stock, worth $11 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
450,000Holding current value
$11 Million% of portfolio
0.03%Shares
3 transactions
Others Institutions Holding ARCT
# of Institutions
196Shares Held
26.7MCall Options Held
294KPut Options Held
318K-
Federated Hermes, Inc. Pittsburgh, PA4.7MShares$114 Million0.37% of portfolio
-
Black Rock Inc. New York, NY2.74MShares$66.8 Million0.0% of portfolio
-
State Street Corp Boston, MA1.96MShares$47.7 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.69MShares$41.1 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.39MShares$33.8 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $647M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...